A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 3, 1998, Pages 139-145

  Eller, N ^a   Kollenz, C J ^a   Hitzenberger, G ^b  

^a Gebro Broschek GmbH   (Austria)

^b Gesellschaft fur Klin Pharmakologie   (Austria)

Author keywords

1 Deamino 8 D arginine vasopressin; Desmopressin intranasally; Desmopressin pharmacokinetics; Urine osmolality; Urine volume

Indexed keywords

DESMOPRESSIN;

ADULT; ANTIDIURESIS; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIURESIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; INTRANASAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; URINE OSMOLALITY; URINE VOLUME;

ADMINISTRATION, INTRANASAL; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CONFIDENCE INTERVALS; CROSS-OVER STUDIES; DEAMINO ARGININE VASOPRESSIN; DIURESIS; HUMANS; MALE; OSMOLAR CONCENTRATION; RADIOIMMUNOASSAY; REFERENCE STANDARDS; RENAL AGENTS; REPRODUCIBILITY OF RESULTS; THERAPEUTIC EQUIVALENCY; URINE;

EID: 0031894464     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Andersson KE, Arner B 1972 Effects of DDAVP, a structural analogue of vasopressin, in patients with central diabetes insipidus. Acta Med Sci 192: 21-27
2. Aronson AS, Andersson KE, Bergstrand CG, Mulder J 1973 Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin. Acta Paed Sci 62: 133-140
3. Becker DJ, Foley TP 1978 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus. J Pediatr 92: 1011-1015
4. Belmaker RH, Bleich A 1986 The use of desmopressin in adult enuresis. Milit Med 151: 660-662
5. Burrow GN, Wassenaar W, Robertson GL, Sehl H 1981 Treatment of diabetes insipidus during pregnancy. Acta Endocrinol 97: 23-25
6. Curtis JR, Donovan BA 1979 Assessment of renal concentrating ability. Br Med J 1: 304-305
7. Delin K, Aurell M, Ewald J 1978 Urinary concentration test with desmopressin. Br Med J 1: 757-758
8. Dimson SW 1977 Desmopressin as a treatment for enuresis. Lancet 1: 1260
9. Du Vigneaud V, Gish DT, Katsoyannis PG 1954 A synthetic preparation possessing biological properties associated with arginine vasopressin. J Am Chem S 76: 4751-4752
10. Edwards CRW, Kitau MJ, Chard T, Besser GM 1973 Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J 3: 375-378
11. Fjellestad-Paulsen A, Tubiana-Rufi N, Harris A, Crernichow P 1987 Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin. Acta Endocrinol 115: 307-312
12. Fjellestad-Paulsen A, Wille S, Harris AS 1987 Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch Dis Child 62: 674-677
13. Fjellestad-Paulsen A, Höglund P, Lundin S, Paulsen O 1993 Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin Endocrinol 38: 177-182
14. Harris AS, Hedner P, Vilhardt H 1987 Nasal administration of desmopressin by spray and drops. J Pharm Pharmacol 39: 932-934
15. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A 1977 DDAVP in haemophilia. Lancet 2: 1171-1172
16. Monson JP, Richards P 1974 Desmopressin urine concentration test. Br Med J 1: 24
17. Note for Guidance 1991 Investigation of bioavailability and bioequivalence. CPMP working party on efficacy of medicinal products. III/54/89-EN
18. Oravec D, Lichardus B 1972 Management of diabetes insipidus in pregnancy. Br Med J 4: 114-115
19. Pedersen PS, Hejl M, Kjller SS 1985 Desamino-8-D-arginine vasopressin in childhood nocturnal enuresis. J Urol 133: 65-66
20. Richardson DW, Robinson AG 1985 Desmopressin. Ann Int Med 103: 228-239
21. Robinson AG 1976 DDAVP in the treatment of central diabetes insipidus. N Engl J Med 294: 507-511
22. Tryding N, Sterner G, Berg B, Harris A, Lundin S 1987 Subcutaneous and intranasal administration of 1-deamino-8-d-arginine vasopressin in the assessment of renal concentration capacity. Nephron 45: 27-30
23. Valiquette G, Herbert J, Meade-D'Alisera P 1996 Desmopressin in the management of nocturia in patients with multiple sclerosis. Arch Neurol 53: 1270-1275
24. Vilhardt H, Aberg M, Nilsson IM 1980 Possible use of DDAVP in coagulation disorders. In: Sutor AH, Schattauer FK (eds) DDAVP in Bleeding Disorders. Schattauer, Stuttgart, pp 36-41
25. Vilhardt H, Lundin S, Falch J 1986 Plasma kinetics of DDAVP in man. Acta Pharm T 58: 379-381
26. Vilhardt H 1990 Basic pharmacology of desmopressin. Drug Invest 2: 2-8
27. Williams TDM, Dunger DB, Lyon CC, Lewis RJ, Taylor F, Lightman SL 1986 Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-d-arginine vasopressin. 1. Studies in adults and children. J Clin End 63: 129-132